Jaguar Health (JAGX) Receivables (2015 - 2026)
Jaguar Health (JAGX) posted quarterly Receivables of $280000.0 for Q1 2026, down 79.84% year-over-year from $1.4 million in Q1 2025, and down 82.81% quarter-over-quarter from $1.6 million in Q4 2025.
Jaguar Health (JAGX) Receivables (2015 - 2026) Analysis & Trends
Jaguar Health (JAGX) has reported Receivables for 12 consecutive years, with $280000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Receivables fell 79.84% year-over-year to $280000.0; the TTM figure through Mar 2026 stood at $280000.0 (down 79.84% YoY), while the FY2025 annual figure was $1.7 million, up 3.1% from the prior year.
- Receivables eased to $280000.0 in Q1 2026 per JAGX's latest filing, from $1.6 million in the prior quarter.
- Across five years, Receivables topped out at $2.5 million in Q3 2022 and bottomed at $280000.0 in Q1 2026.
- Historically, Receivables has averaged $1.6 million across 5 years, with a median of $1.6 million in 2024.
- Annual changes were most pronounced in 2024 — Receivables grew 18.7% — and 2026, when it tumbled 79.84%.
- Jaguar Health's Receivables stood at $1.8 million in 2022, then gained by 11.37% to $2.0 million in 2023, then retreated by 19.87% to $1.6 million in 2024, then increased by 1.75% to $1.6 million in 2025, then slumped by 82.81% to $280000.0 in 2026.
- Business Quant data shows JAGX's Receivables at $280000.0 in Q1 2026, $1.6 million in Q4 2025, and $1.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.77 Bn | 131.91 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.75 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 65.36 Bn | 60.17 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 59.60 Bn | 54.47 Bn | 52.00 Mn | 160.00 Mn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 1.06 Bn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | 912.74 Mn |
| 7 | BioNTech SE | 28.13 Bn | 9.73 Bn | 668.28 Mn | 1.09 Bn |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn | 215.33 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | - |
| 10 | Jaguar Health | 451,262.91 | -9.61 Mn | 19.11 Mn | 280,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 280,000.00 |
| Dec 31, 2025 | 1.63 Mn |
| Sep 30, 2025 | 1.50 Mn |
| Jun 30, 2025 | 1.32 Mn |
| Mar 31, 2025 | 1.39 Mn |
| Dec 31, 2024 | 1.60 Mn |
| Sep 30, 2024 | 1.31 Mn |
| Jun 30, 2024 | 1.36 Mn |
| Mar 31, 2024 | 1.71 Mn |
| Dec 31, 2023 | 2.00 Mn |
| Sep 30, 2023 | 1.85 Mn |
| Jun 30, 2023 | 1.56 Mn |
| Mar 31, 2023 | 1.44 Mn |
| Dec 31, 2022 | 1.79 Mn |
| Sep 30, 2022 | 2.46 Mn |
| Jun 30, 2022 | 2.08 Mn |
| Mar 31, 2022 | 2.26 Mn |
| Dec 31, 2021 | 2.05 Mn |
| Sep 30, 2021 | 2.21 Mn |
| Jun 30, 2021 | 4.17 Mn |